Pharma Co. Seeks To Deny Novartis' 'Speculative' DQ Bid
Shilpa Pharma Inc. has asked the Delaware federal court to reject Novartis Pharmaceuticals Corp.'s bid to disqualify a lawyer representing Shilpa in a patent dispute over a multiple sclerosis drug, arguing...To view the full article, register now.
Already a subscriber? Click here to view full article